• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.

作者信息

Bar M H

机构信息

Columbia University College of Physicians and Surgeons, USA.

出版信息

Conn Med. 2000 Jan;64(1):3-6.

PMID:10697358
Abstract
摘要

相似文献

1
The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.喧嚣与躁动：转移性和高危乳腺癌大剂量化疗及自体干细胞挽救治疗作用的最新进展
Conn Med. 2000 Jan;64(1):3-6.
2
Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
J Clin Oncol. 1999 Nov;17(11 Suppl):22-4.
3
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy.一项随机III期对照试验，比较转移性乳腺癌且仅伴有骨转移的女性在接受强化诱导化疗后立即进行大剂量化疗巩固及自体外周血祖细胞支持与延迟巩固观察的疗效。
Bone Marrow Transplant. 2006 Jun;37(11):1009-15. doi: 10.1038/sj.bmt.1705367.
4
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.多柔比星辅助治疗高危II期乳腺癌，继以大剂量化疗和自体干细胞移植：单机构对132例连续患者的经验。
Bone Marrow Transplant. 2003 Apr;31(8):655-61. doi: 10.1038/sj.bmt.1703856.
5
Dose intensification and breast cancer.剂量强化与乳腺癌
Gan To Kagaku Ryoho. 1997 May;24 Suppl 1:153-77.
6
High-dose therapy in breast cancer: out of favor but not out of promise.乳腺癌的大剂量疗法：虽失宠但仍有前景。
Bone Marrow Transplant. 2000 May;25(10):1017-9. doi: 10.1038/sj.bmt.1702388.
7
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years.高剂量化疗联合自体造血干细胞支持治疗高危原发性乳腺癌的随机试验：12年随访
Cancer. 2006 Jun 1;106(11):2327-36. doi: 10.1002/cncr.21906.
8
High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer.高剂量化疗联合自体造血祖细胞支持治疗转移性和高危原发性乳腺癌。
Semin Oncol. 1996 Feb;23(1 Suppl 2):60-7.
9
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.与标准剂量化疗相比，高剂量化疗联合自体造血干细胞支持用于10个或更多阳性淋巴结的乳腺癌患者：一项随机试验的初步结果
J Clin Oncol. 2004 Jun 15;22(12):2273-83. doi: 10.1200/JCO.2004.07.026. Epub 2004 Apr 26.
10
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.HER-2/neu过表达作为接受大剂量化疗联合自体干细胞移植的转移性乳腺癌患者的不良预后因素。
Clin Cancer Res. 2001 Dec;7(12):4008-12.